- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Live Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Live Vaccinesmarket, defines the market attractiveness level of Live Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Live Vaccines industry, describes the types of Live Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Live Vaccines market and the development prospects and opportunities of Live Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Live Vaccines market in Chapter 13.
By Player:
Emergent BioSolutions
Pfizer
Astellas Pharma
Novartis
AstraZeneca
GlaxoSmithKline
By Type:
Monovalent Live Vaccines
Multivalent Live Vaccines
By End-User:
Adults
Children
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Live Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Live Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Live Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Live Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Live Vaccines Market Analysis and Outlook to 2022
-
7.1 Global Live Vaccines Consumption (2017-2022)
-
7.2 United States Live Vaccines Consumption (2017-2022)
-
7.3 Europe Live Vaccines Consumption (2017-2022)
-
7.4 China Live Vaccines Consumption (2017-2022)
-
7.5 Japan Live Vaccines Consumption (2017-2022)
-
7.6 India Live Vaccines Consumption (2017-2022)
-
7.7 South Korea Live Vaccines Consumption (2017-2022)
8 Region and Country-wise Live Vaccines Market Analysis and Outlook to 2028
-
8.1 Global Live Vaccines Consumption Forecast (2022-2028)
-
8.2 United States Live Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe Live Vaccines Consumption Forecast (2022-2028)
-
8.4 China Live Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan Live Vaccines Consumption Forecast (2022-2028)
-
8.6 India Live Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea Live Vaccines Consumption Forecast (2022-2028)
9 Global Live Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Live Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monovalent Live Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Multivalent Live Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global Live Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Children Consumption and Growth Rate (2017-2022)
10 Global Live Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global Live Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monovalent Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Multivalent Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Live Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Children Consumption Forecast and Growth Rate (2022-2028)
11 Global Live Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Live Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Live Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Live Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Live Vaccines Market Competitive Analysis
-
14.1 Emergent BioSolutions
-
14.1.1 Emergent BioSolutions Company Details
-
14.1.2 Emergent BioSolutions Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Emergent BioSolutions Live Vaccines Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Live Vaccines Product and Service
-
14.3 Astellas Pharma
-
14.3.1 Astellas Pharma Company Details
-
14.3.2 Astellas Pharma Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Astellas Pharma Live Vaccines Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Live Vaccines Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Live Vaccines Product and Service
-
14.6 GlaxoSmithKline
-
14.6.1 GlaxoSmithKline Company Details
-
14.6.2 GlaxoSmithKline Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline Live Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Live Vaccines
-
Figure Live Vaccines Picture
-
Table Global Live Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Live Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Live Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Live Vaccines Consumption by Country (2017-2022)
-
Figure United States Live Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Live Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China Live Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Live Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Live Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Live Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Live Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monovalent Live Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Multivalent Live Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Monovalent Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multivalent Live Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Live Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Live Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Emergent BioSolutions (Foundation Year, Company Profile and etc.)
-
Table Emergent BioSolutions Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent BioSolutions Live Vaccines Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Live Vaccines Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Live Vaccines Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Live Vaccines Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Live Vaccines Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Live Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Live Vaccines Product and Service
-